| Literature DB >> 26123588 |
Charlotte Lepoutre-Lussey1, Constance Thibault1, Alexandre Buffet1, Aurélie Morin1, Cécile Badoual2, Paule Bénit3, Pierre Rustin3, Chris Ottolenghi4, Maxime Janin4, Luis-Jaime Castro-Vega1, Jan Trapman5, Anne-Paule Gimenez-Roqueplo6, Judith Favier7.
Abstract
Pheochromocytomas and paragangliomas (PPGL) are rare neuroendocrine tumors characterized by a high frequency of hereditary forms. Based on transcriptome classification, PPGL can be classified in two different clusters. Cluster 1 tumors are caused by mutations in SDHx, VHL and FH genes and are characterized by a pseudohypoxic signature. Cluster 2 PPGL carry mutations in RET, NF1, MAX or TMEM127 genes and display an activation of the MAPK and mTOR signaling pathways. Many genetically engineered and allografted mouse models have been generated these past 30 years to investigate the mechanisms of PPGL tumorigenesis and test new therapeutic strategies. Among them, only Cluster 2-related models have been successful while no Cluster 1-related knockout mouse was so far reported to develop a PPGL. In this review, we present an overview of existing, successful or not, PPGL models, and a description of our own experience on the quest of Sdhb knockout mouse models of PPGL.Entities:
Keywords: Chromaffin cells; Genetically engineered mouse; Knockout; Pheochromocytoma; Xenograft
Mesh：
Substances：
Year: 2015 PMID： 26123588 DOI： 10.1016/j.mce.2015.06.027
Source DB: PubMed Journal: Mol Cell Endocrinol ISSN： 0303-7207 Impact factor: 4.102